Om Launches Diligence

Om is thrilled to announce the launch of Diligence, our groundbreaking platform for therapeutic opportunity analysis across the entire human proteome. Originally developed internally to systematically prioritize and rank-order over 17,000 proteins for comprehensive screening against hundreds of millions of molecules, we are now opening this powerful analytical tool to the broader research and drug discovery community.

Diligence empowers researchers and drug discovery teams with detailed, data-driven insights into the therapeutic potential of nearly any protein of interest. Leveraging sophisticated machine learning algorithms trained on extensive proprietary datasets, Diligence evaluates proteins based on multiple critical factors including biological relevance, disease associations, druggability, structural attributes, and predicted binding interactions. This thorough analysis helps researchers rapidly identify and prioritize the most promising therapeutic targets.